INSM

Name: INSM Congressional Trading Activity
Creator: Signal Congress

Congressional Activity

Insmed Incorporated - Common Stock (INSM) [ST]

ARIA INTELLIGENCE BRIEF

Disclosure filings show two members of Congress — Gil Cisneros and Josh Gottheimer — have traded INSM, a Health Care sector equity, across four total transactions spanning from June 2025 through June 2026. The balance of activity skews toward selling, with three disclosed sales against one purchase, reflecting a net-selling posture across the filing period. No bipartisan co-trading clusters are recorded for this security, and no executive-branch officials have disclosed transactions in INSM in the public filing record.

Signal Congress surfaces public disclosure data. This is not investment advice and does not imply wrongdoing.

TOTAL TRADES

BUYS

SELLS

MEMBERS

unique traders

BIPARTISAN CLUSTERS

AVG ALPHA 60D

+27.29%

vs SPY benchmark

INSM timeline7 trades · Congress · single source

Positioned by disclosure date. Click any marker for its source filing.

CongressCabinetContract cut8-K13D▲ buy ▼ sell ◆ n/a ■ event

EXECUTIVE HOLDINGS

Primary-source OGE 278-T disclosures

View all on Executive page →

No OGE 278-T disclosures found for INSM.

7 trades

Congressional trading data from STOCK Act filings. Not investment advice.

ABOUT CONGRESSIONAL TRADING IN INSM

As of August 2026, 2 members of Congress have collectively executed 7 disclosed trades on INSM (Insmed Incorporated - Common Stock). This includes 1 purchase and 6 sales, with bipartisan cluster activity detected 0 times — instances where members of both parties traded INSM within overlapping time windows, often a signal of coordinated information or policy-related activity.

MOST-ACTIVE TRADERS

The most active trader of INSM on Signal Congress is Josh Gottheimer with 5 trades, followed by Gil Cisneros (2 trades).

Signal Congress tracks INSM congressional trades through STOCK Act PTR filings from the House Clerk XML feed and Senate eFD system. Each trade is scored for conviction (0–100 scale) based on filing speed, amount, and corroboration signals, and analyzed for alpha generation against the SPY benchmark over 60-day and 180-day windows.